Wuhan Healthgen Biotechnology Corp. (SHA:688765)

China · Delayed Price · Currency is CNY

66.00

+2.47 (3.89%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
Biotechnology	25.22M	24.26M	13.40M	25.52M	21.57M
Biotechnology Growth	3.92%	81.08%	-47.49%	18.33%	110.40%
Total	25.22M	24.26M	13.40M	25.52M	21.57M
Total Growth	3.92%	81.08%	-47.49%	18.33%	110.40%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014
China	12.18M	9.63M	6.60M	9.64M	7.44M
China Growth	26.50%	45.89%	-31.55%	29.57%	224.41%
Overseas	13.04M	14.64M	6.80M	15.88M	14.13M
Overseas Growth	-10.92%	115.21%	-57.16%	12.40%	77.54%
Total	25.22M	24.26M	13.40M	25.52M	21.57M
Total Growth	3.92%	81.08%	-47.49%	18.33%	110.40%

Source: S&P Global Market Intelligence.